Below is a summary assembled by the Research & Innovation Office (RIO). Please see the full solicitation for complete information about the funding opportunity.
The Pathway to Stop Diabetes Program intends to attract brilliant scientists at the peak of their creativity to diabetes research, and to accelerate their research progress by providing the necessary resources and support for conducting transformative science.
The Pathway Accelerator award is intended to provide flexible, long-term salary and research support to early career researchers who are proposing innovative and ambitious diabetes-related research programs, and who have distinguished themselves as exceptionally talented and promising research investigators.
These awards are highly competitive and intended to support particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes with an emphasis on the investigator’s potential to significantly transform diabetes through translational research (‘moving the needle’) to improve the lives of people with diabetes. Candidates for Accelerator awards should be in the process of establishing successful, independent diabetes research programs, and have records of independent productivity in research.
For the purpose of this award, demonstration of independent productivity should include that the candidate is currently in an independent faculty position, has demonstrated the ability to perform a particular set of experiments at a high-quality level, including senior author publications (independent of training mentors) and/or has demonstrated the ability to obtain independent funding/support for their work.
CU Internal Deadline: 11:59pm MST June 27, 2022
Sponsor Application Deadline: 3:00pm MST August 1, 2022
Internal Application Requirements (all in PDF format)
- Project Summary (3 pages maximum): Please describe the investigator’s potential to significantly transform diabetes through translational research (‘moving the needle’) to improve the lives of people with diabetes. Also describe the investigator’s proven creativity, collaboration and innovation, and ability to establish an independent research program.
- PI CV / Biosketch
- Budget Overview (up to 1 page): A basic budget outlining project costs is sufficient; detailed OCG budgets are not required.
To access the online application, visit: https://cuboulderovcr.secure-platform.com/a/solicitations/6756/home
Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award.
Co-PIs are not permitted.
Limited Submission Guidelines
Each institution is allowed a maximum of one nomination per grant cycle. The nomination can be for one of the Pathway Program Award types: Initiator or Accelerator. Accelerator awards are designed for faculty and the award type being pursued by CU Boulder.
Accelerator Award: $325,000/year over 5 years
- Proven ability to establish independent research program
- Proven ability for creativity, collaboration and innovation
- Institutional commitment
- Innovation and creativity
- Potential impact for understanding/treatment of diabetes
- Clarity of thought and approach